Related Experiment Video
Updated: Feb 10, 2026

Flow Cytometric Detection of Newly-formed Breast Cancer Stem Cell-like Cells After Apoptosis Reversal
Published on: January 26, 2019
Cytokeratin 8/18 protects breast cancer cell lines from TRAIL-induced apoptosis
William P Bozza1, Yaqin Zhang1, Baolin Zhang1
1Office of Biotechnology Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.
Abstract:
TNF-related apoptosis inducing ligand (TRAIL) induces apoptosis by engaging its death receptors (DRs) 4 and/or 5 on targeted cells. Clinical attempts to stimulate this apoptotic pathway for cancer therapy, including the use of recombinant human TRAIL (rhTRAIL) or receptor agonistic antibodies, have been underway for over a decade. Unfortunately, these agents have only shown limited therapeutic effects due largely to tumor resistance arising from mechanisms yet to be defined. Here we show that intermediate filament proteins, keratin 8 and keratin 18 (K8/K18), negatively regulate TRAIL induced apoptosis. K8/K18 protein levels are consistently higher in TRAIL-resistant cells compared to TRAIL-sensitive cells in a panel of breast cancer cell lines. Blockade of K8 increased expression of DR5 on the surface of targeted cells and sensitized the cells to TRAIL-induced apoptosis. Conversely, ectopic expression of K8/K18 downregulated DR5 protein expression. K8/K18 appears to negatively regulate apoptosis signaling via DR5 in breast cancer cells. Our findings warrant additional studies to determine if K8/K18 could be a predictor of tumor resistance to DR5-targeted therapies.
Insights
Keratin 8/18 proteins reduce cancer cell death signaling via TRAIL. Lowering these keratins may improve effectiveness of TRAIL-based cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Pathways
Background:
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis through death receptors (DRs) 4 and/or 5.
- Clinical applications of TRAIL-based cancer therapies show limited efficacy due to undefined resistance mechanisms.
Purpose of the Study:
- To investigate the role of intermediate filament proteins, keratin 8 and keratin 18 (K8/K18), in regulating TRAIL-induced apoptosis.
- To explore K8/K18 as a potential mechanism of resistance to TRAIL-targeted cancer therapies.
Main Methods:
- Comparative analysis of K8/K18 protein levels in TRAIL-sensitive versus TRAIL-resistant breast cancer cell lines.
- Investigating the effects of K8 blockade and K8/K18 ectopic expression on DR5 levels and TRAIL sensitivity.
Main Results:
- Higher K8/K18 protein levels correlate with TRAIL resistance in breast cancer cells.
- K8 blockade enhances surface DR5 expression and TRAIL-induced apoptosis.
- Ectopic expression of K8/K18 downregulates DR5 protein levels.
Conclusions:
- Keratin 8/18 negatively regulates TRAIL-induced apoptosis signaling through DR5 in breast cancer.
- K8/K18 may serve as a predictive biomarker for resistance to DR5-targeted cancer therapies.
Related Concept Videos
Cell Lines
Apoptosis
Mechanisms of Retrovirus-induced Cancers
Protection of Alcohols
Protection
It defines a protecting group as the masking agent to make the more reactive species inert to a given set of conditions. This concept is depicted via the illustration of liquid flow through different outlets in an assembly of pipes. The analogy helps to understand the role...
Zones of Protection
Protective zones are defined by closed dashed lines, containing one or more components. A key characteristic of these zones is the strategic placement of...
Protecting Self-Esteem

